AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Stock Information for Anavex Life Sciences Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Anavex Life Sciences Corp.

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference
Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Anavex Life Sciences Announces Expansion of Leadership Team
NASDAQ: AVXL Investor Notice: Update in Lawsuit for Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) announced by the Shareholders Foundation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.